Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Androgenetic alopecia in women needs more research and better management strategies.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Moringa seed oil may help prevent hair loss and promote hair growth.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.